Human Papillomavirus Infection in Women Who Submit Self-collected Vaginal Swabs After Internet Recruitment
Submission of vaginal samples collected at home could remove barriers that women face in getting screened for cervical cancer. From December 2013 to January 2014, women aged 21–30 years were recruited online to participate in either (1) self-collected testing for human papillomavirus (HPV) infection and an online survey, or (2) an online survey regarding their perceptions of self-collected testing for HPV infection. Demographics, risk factors, testing perceptions, and satisfaction with self-collected testing were assessed with online questionnaires. Women who performed self-collection were sent a home sampling kit by US mail, which was returned via US mail for HPV testing. A total of 197 women were enrolled, with 130 completing the online survey and 67 participating in both the survey and self-collection. Of the 67 women who were sent kits, 62 (92.5 %) were returned for testing. Sixty kits contained a sample sufficient for testing. The overall prevalence of HPV infection was 17.8 %, however 6 women (9.7 %) were infected with >1 type of HPV. Women who self-collected a sample reported more favorable attributes of self-collection compared to women who only participated in the online survey, including ease of sampling (87.1 vs. 18.9 %), no pain during sampling (72.6 vs. 5.6 %), and lack of embarrassment (67.7 vs. 12.9 %). A high prevalence of HPV infection was demonstrated among women recruited via the internet. Online recruitment and at home screening methods have the potential to engage women in screening by offering an approach that might be more acceptable to women of different backgrounds.
KeywordsHuman papillomavirus testing Self-collection Cervical cancer Internet recruitment
This study was supported by the J.B. Hawley Student Research Award from the University of Minnesota School of Public Health and by the Minnesota Medical Foundation through Grant #4120-9227-12.
Conflict of interest
There are no conflicts of interest for any authors of this paper.
- 3.de Sanjose, S., Diaz, M., Castellsague, X., Clifford, G., Bruni, L., Munoz, N., et al. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. The Lancet infectious diseases, 7(7), 453–459.CrossRefPubMedGoogle Scholar
- 6.Clifford, G. M., Gallus, S., Herrero, R., Munoz, N., Snijders, P. J., Vaccarella, S., et al. (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet, 366(9490), 991–998.CrossRefPubMedGoogle Scholar
- 7.Moscicki, A. B., Schiffman, M., Kjaer, S., Villa, L. L. (2006). Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine, 24(Suppl 3), S3/42–51.Google Scholar
- 9.Cuschieri, K. S., Cubie, H. A., Whitley, M. W., Gilkison, G., Arends, M. J., Graham, C., et al. (2005). Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. Journal of Clinical Pathology, 58(9), 946–950.CrossRefPubMedCentralPubMedGoogle Scholar
- 12.U.S. Food and Drug Administration. (2014). FDA approves first human papillomavirus test for primary cervical cancer screening. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm; http://www.webcitation.org/6RwkQR875.
- 15.Harper, D. M., Noll, W. W., Belloni, D. R., & Cole, B. F. (2002). Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed–biologic concordance and women’s preferences. American Journal of Obstetrics and Gynecology, 186(3), 365–373.CrossRefPubMedGoogle Scholar
- 16.Lorenzato, F. R., Singer, A., Ho, L., Santos, L. C., Batista Rde, L., Lubambo, T. M., et al. (2002). Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples. American journal of Obstetrics and Gynecology, 186(5), 962–968.CrossRefPubMedGoogle Scholar
- 18.Gravitt, P. E., Lacey, J. V, Jr, Brinton, L. A., Barnes, W. A., Kornegay, J. R., Greenberg, M. D., et al. (2001). Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiology Biomarkers and Prevention, 10(2), 95–100.Google Scholar
- 20.Dzuba, I. G., Diaz, E. Y., Allen, B., Leonard, Y. F., Lazcano Ponce, E. C., Shah, K. V., et al. (2002). The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. Journal of Womens Health and Gender Based Medicine, 11(3), 265–275.CrossRefGoogle Scholar
- 23.Pew Research Internet Project. (2014). Social networking fact sheet. Washington, DC. http://www.pewinternet.org/fact-sheets/social-networking-fact-sheet/; http://www.webcitation.org/6P3HgIRa0.
- 24.Scarinci, I. C., Litton, A. G., Garces-Palacio, I. C., Partridge, E. E., & Castle, P. E. (2013). Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues, 23(2), e123–e130.CrossRefPubMedCentralPubMedGoogle Scholar
- 28.Nelson, E. J., Hughes, J., Oakes, J. M., Pankow, J. S., & Kulasingam, S. (2014). Estimation of geographic variation in human papillomavirus vaccine uptake in men and women: An online survey using facebook recruitment. Journal of Medical Internet Research, 16(9), e198.Google Scholar
- 29.Ralston Howe, E., Li, Z., McGlennen, R. C., Hellerstedt, W. L., & Downs, L. S. (2009). Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening. American Journal of Obstetrics and Gynecology, 200(3), 245.e1–245.e7.CrossRefGoogle Scholar
- 30.Ogilvie, G. S., Mitchell, S., Sekikubo, M., Biryabarema, C., Byamugisha, J., Jeronimo, J., et al. (2013). Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. International Journal of Gynecology and Obstetrics, 122(2), 118–123.CrossRefPubMedGoogle Scholar
- 32.Richardson, E., Sellors, J. W., Mackinnon, S., Woodcox, V., Howard, M., Jang, D., et al. (2003). Prevalence of Chlamydia trachomatis infections and specimen collection preference among women, using self-collected vaginal swabs in community settings. Sexually Transmitted Diseases, 30(12), 880–885.CrossRefPubMedGoogle Scholar
- 35.Goldhaber-Fiebert, J. D., Stout, N. K., Salomon, J. A., Kuntz, K. M., & Goldie, S. J. (2008). Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. Journal of the National Cancer Institute, 100(5), 308–320.CrossRefPubMedCentralPubMedGoogle Scholar